
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma
Martin K. Thomsen, Morten Kelder Skouboe, Cédric Boularan, et al.
Oncogene (2019) Vol. 39, Iss. 8, pp. 1652-1664
Closed Access | Times Cited: 73
Martin K. Thomsen, Morten Kelder Skouboe, Cédric Boularan, et al.
Oncogene (2019) Vol. 39, Iss. 8, pp. 1652-1664
Closed Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, J Filderman, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2695-2695
Open Access | Times Cited: 268
Afsaneh Amouzegar, Manoj Chelvanambi, J Filderman, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2695-2695
Open Access | Times Cited: 268
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Juyan Zheng, Junluan Mo, Tao Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 198
Juyan Zheng, Junluan Mo, Tao Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 198
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Leila Motedayеn Aval, James E. Pease, Rohini Sharma, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3323-3323
Open Access | Times Cited: 176
Leila Motedayеn Aval, James E. Pease, Rohini Sharma, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3323-3323
Open Access | Times Cited: 176
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura, Takanori Sato, Rikito Endo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002852-e002852
Open Access | Times Cited: 174
Takashi Nakamura, Takanori Sato, Rikito Endo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002852-e002852
Open Access | Times Cited: 174
Genomic instability, inflammatory signaling and response to cancer immunotherapy
Mengting Chen, Renske Linstra, Marcel A.T.M. van Vugt
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188661-188661
Open Access | Times Cited: 110
Mengting Chen, Renske Linstra, Marcel A.T.M. van Vugt
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188661-188661
Open Access | Times Cited: 110
Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man, Brendan J. Jenkins
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 397-413
Closed Access | Times Cited: 80
Si Ming Man, Brendan J. Jenkins
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 397-413
Closed Access | Times Cited: 80
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 65
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 65
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
The role of cGAS-STING signalling in liver diseases
Ruihan Chen, Jiamin Du, Hong Zhu, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100324-100324
Open Access | Times Cited: 68
Ruihan Chen, Jiamin Du, Hong Zhu, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100324-100324
Open Access | Times Cited: 68
Disrupted BRCA1‐PALB2 interaction induces tumor immunosuppression and T‐lymphocyte infiltration in HCC through cGAS‐STING pathway
Hui Ma, Zhihua Kang, Tzeh Keong Foo, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 33-47
Open Access | Times Cited: 56
Hui Ma, Zhihua Kang, Tzeh Keong Foo, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 33-47
Open Access | Times Cited: 56
A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology
Thaneas Prabakaran, Anne Troldborg, Sarinya Kumpunya, et al.
EBioMedicine (2021) Vol. 66, pp. 103314-103314
Open Access | Times Cited: 54
Thaneas Prabakaran, Anne Troldborg, Sarinya Kumpunya, et al.
EBioMedicine (2021) Vol. 66, pp. 103314-103314
Open Access | Times Cited: 54
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 30
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 30
The cGAS-STING pathway: a therapeutic target in diabetes and its complications
Wenjie He, Xingrui Mu, Xingqian Wu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 13
Wenjie He, Xingrui Mu, Xingqian Wu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 13
IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
Xu He, Abdalla M. Wedn, Jian Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107063-107063
Open Access | Times Cited: 12
Xu He, Abdalla M. Wedn, Jian Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107063-107063
Open Access | Times Cited: 12
Inhibition of Sirt3 activates the cGAS-STING pathway to aggravate hepatocyte damage in hepatic ischemia–reperfusion injury mice
Erliang Kong, Yang Zhang, Xuqiang Geng, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111474-111474
Closed Access | Times Cited: 9
Erliang Kong, Yang Zhang, Xuqiang Geng, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111474-111474
Closed Access | Times Cited: 9
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
Zhenhua Qi, Yan Fang, Dongtai Chen, et al.
Bioscience Reports (2020) Vol. 40, Iss. 10
Open Access | Times Cited: 62
Zhenhua Qi, Yan Fang, Dongtai Chen, et al.
Bioscience Reports (2020) Vol. 40, Iss. 10
Open Access | Times Cited: 62
Regulation and inhibition of the DNA sensor cGAS
Jonny Hertzog, Jan Rehwinkel
EMBO Reports (2020) Vol. 21, Iss. 12
Open Access | Times Cited: 49
Jonny Hertzog, Jan Rehwinkel
EMBO Reports (2020) Vol. 21, Iss. 12
Open Access | Times Cited: 49
The cGAS-STING Pathway: Novel Perspectives in Liver Diseases
Dongwei Xu, Yizhu Tian, Qiang Xia, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
Dongwei Xu, Yizhu Tian, Qiang Xia, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis
Yuqi Li, Minjing He, Ziyu Wang, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 92-107
Open Access | Times Cited: 46
Yuqi Li, Minjing He, Ziyu Wang, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 92-107
Open Access | Times Cited: 46
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 28
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 28
Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation
Xiaoquan Wang, Youqiao Wang, Anqi Cao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Xiaoquan Wang, Youqiao Wang, Anqi Cao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases
Jin Kyung Seok, Minhyuk Kim, Han Chang Kang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 6, pp. 500-534
Open Access | Times Cited: 17
Jin Kyung Seok, Minhyuk Kim, Han Chang Kang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 6, pp. 500-534
Open Access | Times Cited: 17
STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)
Jiale Liu, Chenmian Liu, Yana Ma, et al.
Cancer Letters (2024) Vol. 588, pp. 216700-216700
Open Access | Times Cited: 5
Jiale Liu, Chenmian Liu, Yana Ma, et al.
Cancer Letters (2024) Vol. 588, pp. 216700-216700
Open Access | Times Cited: 5
Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
Aifang Nie, Zimo Xiao, Jiali Deng, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Aifang Nie, Zimo Xiao, Jiali Deng, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Nanodelivery of arsenic trioxide induces macrophage-governed cGAS-STING signaling to remodel immune microenvironment in hepatocellular carcinoma
Yuyao Li, Jia Shi, Shihan Yu, et al.
Chemical Engineering Journal (2025), pp. 159943-159943
Closed Access
Yuyao Li, Jia Shi, Shihan Yu, et al.
Chemical Engineering Journal (2025), pp. 159943-159943
Closed Access